ELAN (Elanco Animal Health) Moat Score: 5/10 (As of Jul. 05, 2026)


ELAN Elanco Animal Health Inc ELAN
66 GF Score
Price $25.00
GF Value $15.58
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Elanco Animal Health Moat Score?

Elanco Animal Health ELAN +3.78% 66 Moat Score is 5 as of Jul. 05, 2026. GuruFocus rates ELAN with a GF Score™ of 66/100 and a GF Value™ of $15.58 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,030 Drug Manufacturers companies, Elanco Animal Health ranks better than 94.66% on this metric.

Elanco Animal Health has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Elanco Animal Health has Narrow Moat: Elanco Animal Health Inc benefits from a solid narrow moat due to its valuable intellectual property and strong distribution network. However, it faces competition that limits its pricing power and market share.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Elanco Animal Health might have Narrow Moat - Solid narrow moat.

Elanco Animal Health  (NYSE:ELAN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Elanco Animal Health Moat Score Related Terms

ELAN vs ALKS, HIMS, NBIX: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanco Animal Health Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's Moat Score distribution charts can be found below:

* The bar in red indicates where Elanco Animal Health's Moat Score falls into.


ELAN
66GF Score
Elanco Animal Health Inc ELAN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Elanco Animal Health (ELAN) has a Moat Score of 5 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Elanco Animal Health ranks #55 out of 1030 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is Elanco Animal Health's Moat Score too high?
Elanco Animal Health's current Moat Score is 5. Based on the distribution chart, Elanco Animal Health ranks #55 out of 1030 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Elanco Animal Health has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's Moat Score compare to ALKS and HIMS?
According to the Drug Manufacturers industry distribution chart, Elanco Animal Health ranks #55 out of 1030 companies for Moat Score. This places Elanco Animal Health in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Elanco Animal Health's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Elanco Animal Health (ELAN) is currently considered Significantly Overvalued. The stock's GF Value™ is $15.58, compared to a current price of $25.00 — trading 60.5% above its estimated fair value. The current Moat Score is 5. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Elanco Animal Health (ELAN), the current Moat Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elanco Animal Health (ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of $25.00 is trading 60.5% above its estimated GF Value™ of $15.58. GuruFocus considers Elanco Animal Health to be Significantly Overvalued.

Key valuation signals for ELAN:

  • Moat Score: 5
  • GF Value™: $15.58 vs. price of $25.00 (60.5% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Other Exchanges 5EA:Germany
Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score

Get the complete analysis for ELAN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.00
Price
$15.58
GF Value